Factor D.
MASP-1
MASP-3
alternative pathway
factor D
lectin pathway
Journal
Immunological reviews
ISSN: 1600-065X
Titre abrégé: Immunol Rev
Pays: England
ID NLM: 7702118
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
pubmed:
2
11
2022
medline:
20
1
2023
entrez:
1
11
2022
Statut:
ppublish
Résumé
Complement factor D (FD) is a serine protease that plays an essential role in the activation of the alternative pathway (AP) by cleaving complement factor B (FB) and generating the C3 convertases C3(H
Substances chimiques
Complement Factor D
EC 3.4.21.46
Mannose-Binding Protein-Associated Serine Proteases
EC 3.4.21.-
Complement System Proteins
9007-36-7
MASP-3 protein, mouse
EC 3.4.21.-
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
15-24Informations de copyright
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Morgan BP. Complement: Clinical Aspects and Relevance to Disease. Academic Press; 1990:228.
Killick J, Morisse G, Sieger D, Astier AL. Complement as a regulator of adaptive immunity. Semin Immunopathol. 2018;40:37-48.
Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11:785-797.
Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344:1058-1066.
Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol. 2002;2:346-353.
Lachmann PJ, Halbwachs L. The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation. Clin Exp Immunol. 1975;21:109-114.
Pangburn MK, Schreiber RD, Müller-Eberhard HJ. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J Exp Med. 1981;154:856-867.
Harboe M, Mollnes TE. The alternative complement pathway revisited. J Cell Mol Med. 2008;12:1074-1084.
Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med. 1980;151:501-516.
Cook KS, Min HY, Johnson D, et al. Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science. 1987;237:402-405.
Choy LN, Rosen BS, Spiegelman BM. Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem. 1992;267:12736-12741.
White RT, Damm D, Hancock N, et al. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem. 1992;267:9210-9213.
Gómez-Banoy N, Guseh JS, Li G, et al. Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans. Nat Med. 2019;25:1739-1747.
Barnum SR, Schein TN. The Complement FactsBook. 2nd ed. Academic Press; 2018:514.
Volanakis JE, Barnum SR, Kilpatrick JM. Purification and properties of human factor D. Methods Enzymol. 1993;223:82-97.
Takahashi M, Ishida Y, Iwaki D, et al. Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D. J Exp Med. 2010;207:29-37.
Fearon DT, Austen KF, Ruddy S. Properdin factor D: characterization of its active site and isolation of the precursor form. J Exp Med. 1974;139:355-366.
Taylor FR, Bixler SA, Budman JI, et al. Induced fit activation mechanism of the exceptionally specific serine protease, complement factor D. Biochemistry. 1999;38:2849-2859.
Barnum SR, Niemann MA, Kearney JF, Volanakis JE. Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay. J Immunol Methods. 1984;67:303-309.
Volanakis JE, Barnum SR, Giddens M, Galla JH. Renal filtration and catabolism of complement protein D. N Engl J Med. 1985;312:395-399.
Xu Y, Ma M, Ippolito GC, Schroeder HW Jr, Carroll MC, Volanakis JE. Complement activation in factor D-deficient mice. Proc Natl Acad Sci U S A. 2001;98:14577-14582.
Skjoedt MO, Hummelshoj T, Palarasah Y, et al. A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation. J Biol Chem. 2010;285:8234-8243.
Degn SE, Jensen L, Hansen AG, et al. Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway activation. J Immunol. 2012;189:3957-3969.
Thielens NM, Cseh S, Thiel S, et al. Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL. J Immunol. 2001;166:5068-5077.
Phillips AE, Toth J, Dodds AW, et al. Analogous interactions in initiating complexes of the classical and lectin pathways of complement. J Immunol. 2009;182:7708-7717.
Teillet F, Gaboriaud C, Lacroix M, Martin L, Arlaud GJ, Thielens NM. Crystal structure of the CUB1-EGF-CUB2 domain of human MASP-1/3 and identification of its interaction sites with mannan-binding lectin and ficolins. J Biol Chem. 2008;283:25715-25724.
Kusakari K, Machida T, Ishida Y, et al. The complex formation of MASP-3 with pattern recognition molecules of the lectin complement pathway retains MASP-3 in the circulation. Front Immunol. 2022;13:907023.
Ambrus G, Gál P, Kojima M, et al. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments. J Immunol. 2003;170:1374-1382.
Degn SE, Jensenius JC, Thiel S. Disease-causing mutations in genes of the complement system. Am J Hum Genet. 2011;88:689-705.
Degn S, Jensen L, Olszowski T, Jensenius JC, Thiel S. Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44. J Immunol. 2013;191:1334-1345.
Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med. 1992;176:1497-1502.
Thiel S, Vorup-Jensen T, Stover CM, et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature. 1997;386:506-510.
Dahl MR, Thiel S, Matsushita M, et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity. 2001;15:127-135.
Iwaki D, Kanno K, Takahashi M, et al. Small mannose-binding lectin-associated protein plays a regulatory role in the lectin complement pathway. J Immunol. 2006;177:8626-8632.
Iwaki D, Kanno K, Takahashi M, Endo Y, Matsushita M, Fujita T. The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway. J Immunol. 2011;187:3751-3758.
Dobó J, Szakács D, Oroszlán G, et al. MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked. Sci Rep. 2016;6:31877.
Pihl R, Jensen L, Hansen AG, et al. Analysis of factor D isoforms in Malpuech-Michels-Mingarelli-Carnevale patients highlights the role of MASP-3 as a maturase in the alternative pathway of complement. J Immunol. 2017;199:2158-2170.
Oroszlán G, Dani R, Szilágyi A, et al. Extensive basal level activation of complement mannose-binding lectin-associated serine protease-3: kinetic modeling of lectin pathway activation provides possible mechanism. Front Immunol. 2017;8:1821.
Hayashi M, Machida T, Ishida Y, et al. Cutting Edge: Role of MASP-3 in the physiological activation of factor D of the alternative complement pathway. J Immunol. 2019;203:1411-1416.
Oroszlán G, Dani R, Végh BM, et al. Proprotein convertase is the highest-level activator of the alternative complement pathway in the blood. J Immunol. 2021;206:2198-2205.
Dobó J, Kocsis A, Dani R, Gál P. Proprotein convertases and the complement system. Front Immunol. 2022;13:958121.
Sirmaci A, Walsh T, Akay H, et al. MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes. Am J Hum Genet. 2010;87:679-686.
Rooryck C, Diaz-Font A, Osborn DPS, et al. Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome. Nat Genet. 2011;43:197-203.
Munye MM, Diaz-Font A, Ocaka L, et al. COLEC10 is mutated in 3MC patients and regulates early craniofacial development. PLoS Genet. 2017;13:e1006679.
Sprong T, Roos D, Weemaes C, et al. Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections. Blood. 2006;107:4865-4870.
Lo JC, Ljubicic S, Leibiger B, et al. Adipsin is an adipokine that improves β cell function in diabetes. Cell. 2014;158:41-53.
Sim RB, Reboul A, Arlaud GH, Villiers CL, Colomb MG. Interaction of 125I-labelled complement subcomponents C1r and C1s with protease inhibitors in plasma. FEBS Lett. 1979;97:111-115.
Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol. 2000;165:2637-2642.
Gigli I, Fujita T, Nussenzweig V. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc Natl Acad Sci U S A. 1979;76:6596-6600.
Fearon DT. Cellular receptors for fragments of the third component of complement. Immunol Today. 1984;5:105-110.
Pangburn MK, Schreiber RD, Müller-Eberhard HJ. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J Exp Med. 1977;146:257-270.
Nicholson-Weller A, March JP, Rosenfeld SI, Austen KF. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein decay-accelerating factor. Proc Natl Acad Sci U S A. 1983;80:5066-5070.
Pangburn MK, Schreiber RD, Müller-Eberhard HJ. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A. 1983;80:5430-5434.
Lesavre PH, Müller-Eberhard HJ. Mechanism of action of factor D of the alternative complement pathway. J Exp Med. 1978;148:1498-1509.
Volanakis VE, Narayana SVL. Complement factor D, a novel serine protease. Protein Sci. 1996;5:553-564.
Sanders PW, Volanakis JE, Rostand SG, Galla JH. Human complement protein D catabolism by the rat kidney. J Clin Invest. 1986;77:1299-1304.
Pascual M, Steiger G, Estreicher J, Macon K, Volanakis JE, Schifferli JA. Metabolism of complement factor D in renal failure. Kidney Int. 1988;34:529-536.
Kluin-Nelemans HC, van Velzen-Blad H, van Helden HP, Daha MR. Functional deficiency of complement factor D in a monozygous twin. Clin Exp Immunol. 1984;58:724-730.
Hiemstra PS, Langeler E, Compier B, et al. Complete and partial deficiencies of complement factor D in a Dutch family. J Clin Invest. 1989;84:1957-1961.
Weiss SJ, Ahmed AE, Bonagura VR. Complement factor D deficiency in an infant first seen with pneumococcal neonatal sepsis. J Allergy Clin Immunol. 1998;102:1043-1044.
Biesma DH, Hannema AJ, van Velzen-Blad H, et al. A family with complement factor D deficiency. J Clin Invest. 2001;108:233-240.
Arlaud GJ, Volanakis JE, Thielens NM, et al. The atypical serine proteases of the complement system. Adv Immunol. 1998;69:249-307.
Sng CCT, O'Byrne S, Prigozhin DM, et al. A type III complement factor D deficiency: structural insights for inhibition of the alternative pathway. J Allergy Clin Immunol. 2018;142:311-314.
Agaoglu NB, Akgun DO. Further expansion of the mutational spectrum of 3MC syndrome: a novel MASP1 pathogenic variant in a male patient. Mol Syndromol. 2021;12:379-385.
Atik T, Koparir A, Bademci G, et al. Novel MASP1 mutations are associated with an expanded phenotype in 3MC1 syndrome. Orphanet J Rare Dis. 2015;10:128.
Ruseva MM, Takahashi M, Fujita T, Pickering MC. C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo. Clin Exp Immunol. 2014;176:84-92.
Hoffmann JA, Kafatos FC, Janeway CA Jr, Ezekowitz RAB. Phylogenetic perspectives in innate immunity. Science. 1999;284:1313-1318.
Müller WEG, Blumbach B, Müller IM. Evolution of the innate and adaptive immune systems: relationships between potential immune molecules in the lowest metazoan phylum (Porifera) and those in vertebrates. Transplantation. 1999;68:1215-1227.
Zarkadis IK, Mastellos D, Lambris JD. Phylogenetic aspects of the complement system. Dev Comp Immunol. 2001;25:745-762.
Riesgo A, Farrar N, Windsor PJ, Giribet G, Leys SP. The analysis of eight transcriptomes from all poriferan classes reveals surprising genetic complexity in sponges. Mol Biol Evol. 2014;31:1102-1120.
Poole AZ, Kitchen SA, Weis VM. The role of complement in cnidarian-dinoflagellate symbiosis and immune challenge in the sea anemone Aiptasia pallida. Front Microbiol. 2016;7:519.
Fujita T, Endo Y, Nonaka M. Primitive complement system--recognition and activation. Mol Immunol. 2004;41:103-111.
Nonaka M. Evolution of the complement system. Subcell Biochem. 2014;80:31-43.
Matsushita M. The complement system of agnathans. Front Immunol. 2018;9:1405.
Endo Y, Nonaka M, Saiga H, et al. Origin of mannose-binding lectin-associated serine protease (MASP)-1 and MASP-3 involved in the lectin complement pathway traced back to the invertebrate, amphioxus. J Immunol. 2003;170:4701-4707.
Ding C, Xiao T, Qin B, Xu B, Lv Z, Wang H. Functional identification of complement factor D and analysis of its expression during GCRV infection in grass carp (Ctenopharyngodon idella). Int J Mol Sci. 2021;22:12011.